BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31804389)

  • 1. Intraductal Papillary Mucinous Neoplasms: Have IAP Consensus Guidelines Changed our Approach?: Results from a Multi-institutional Study.
    Pulvirenti A; Margonis GA; Morales-Oyarvide V; McIntyre CA; Lawrence SA; Goldman DA; Gonen M; Weiss MJ; Ferrone CR; He J; Brennan MF; Cameron JL; Lillemoe KD; Kingham TP; Balachandran V; Qadan M; D'Angelica MI; Jarnagin WR; Wolfgang CL; Castillo CF; Allen PJ
    Ann Surg; 2021 Dec; 274(6):e980-e987. PubMed ID: 31804389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
    Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm.
    Tang RS; Weinberg B; Dawson DW; Reber H; Hines OJ; Tomlinson JS; Chaudhari V; Raman S; Farrell JJ
    Clin Gastroenterol Hepatol; 2008 Jul; 6(7):815-9; quiz 719. PubMed ID: 18602036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of the sendai consensus guidelines for branch-duct intraductal papillary mucinous neoplasms: a systematic review.
    Goh BK; Tan DM; Ho MM; Lim TK; Chung AY; Ooi LL
    J Gastrointest Surg; 2014 Jul; 18(7):1350-7. PubMed ID: 24668367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
    Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
    Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Branch duct intraductal papillary mucinous neoplasm - contra resection].
    Brunner M; Weber GF; Kersting S; Grützmann R
    Chirurg; 2017 Nov; 88(11):918-926. PubMed ID: 28871376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic Resection for Side-Branch Intraductal Papillary Mucinous Neoplasm (SB-IPMN): a Contemporary Single-Institution Experience.
    Dortch JD; Stauffer JA; Asbun HJ
    J Gastrointest Surg; 2015 Sep; 19(9):1603-9. PubMed ID: 26055134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
    Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
    Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of Fukuoka Criteria and Patient Management in Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs) During Follow-Up.
    Schellhaas B; Vitali F; Wildner D; Görtz RS; Pfeifer L; Konturek PC; Neurath MF; Strobel D
    Med Sci Monit; 2017 Mar; 23():1483-1492. PubMed ID: 28348359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Branch duct intraductal papillary mucinous neoplasm - surgical approach].
    Kaiser J; Büchler MW; Hackert T
    Chirurg; 2017 Nov; 88(11):927-933. PubMed ID: 28801818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
    Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
    Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancer.
    Nguyen AH; Toste PA; Farrell JJ; Clerkin BM; Williams J; Muthusamy VR; Watson RR; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
    J Gastrointest Surg; 2015 Feb; 19(2):258-65. PubMed ID: 25373706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct.
    Sahora K; Fernández-del Castillo C; Dong F; Marchegiani G; Thayer SP; Ferrone CR; Sahani DV; Brugge WR; Warshaw AL; Lillemoe KD; Mino-Kenudson M
    Surgery; 2014 Sep; 156(3):611-21. PubMed ID: 25081232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Fukuoka Consensus Guidelines for intraductal papillary mucinous neoplasms of the pancreas: Results from a systematic review of 1,382 surgically resected patients.
    Goh BK; Lin Z; Tan DM; Thng CH; Khor CJ; Lim TK; Ooi LL; Chung AY
    Surgery; 2015 Nov; 158(5):1192-202. PubMed ID: 26032832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms.
    Jang JY; Park T; Lee S; Kang MJ; Lee SY; Lee KB; Chang YR; Kim SW
    Br J Surg; 2014 May; 101(6):686-92. PubMed ID: 24668442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
    Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
    Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.
    Sahora K; Mino-Kenudson M; Brugge W; Thayer SP; Ferrone CR; Sahani D; Pitman MB; Warshaw AL; Lillemoe KD; Fernandez-del Castillo CF
    Ann Surg; 2013 Sep; 258(3):466-75. PubMed ID: 24022439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Branch-duct intraductal papillary mucinous neoplasm (IPMN): Are cyst volumetry and other novel imaging features able to improve malignancy prediction compared to well-established resection criteria?
    Pozzi Mucelli RM; Moro CF; Del Chiaro M; Valente R; Blomqvist L; Papanikolaou N; Löhr JM; Kartalis N
    Eur Radiol; 2022 Aug; 32(8):5144-5155. PubMed ID: 35275259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.